Company Profile

Enovis Corporation

Profile date: 2026-05-15

Company Overview

Introduction

Enovis Corporation (NYSE: ENOV) is a leading global medical technology innovator focused on developing clinically differentiated orthopedic solutions that enhance patient outcomes and restore human motion. Headquartered in Wilmington, Delaware, USA, Enovis was formed in February 2022 following the corporate spin-off and rebranding of Colfax Corporation's fabrication technology segment, which allowed the remaining multi-billion dollar business to focus entirely on medical technology.

Enovis operates as a vertically integrated entity spanning research and development, clinical manufacturing, regulatory tracking, and global commercial distribution. The company utilizes a unique, formalized operational management methodology called Enovis Growth Excellence (EGX), which drives systematic, continuous improvement across all design, safety, and inventory pipelines. Employing over 7,000 personnel across more than 30 advanced corporate manufacturing plants and R&D facilities worldwide, Enovis maintains a deep portfolio of over 1,200 active medical patents and generates substantial commercial revenues supporting orthopedic surgeons, physical therapists, athletic trainers, and hospital networks globally.

Please note: This information is generated by AI. For legal use, verify with company sources.